A detailed history of Boenning & Scattergood, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Boenning & Scattergood, Inc. holds 5,311 shares of BSX stock, worth $481,973. This represents 0.04% of its overall portfolio holdings.

Number of Shares
5,311
Previous 5,399 1.63%
Holding current value
$481,973
Previous $209,000 12.44%
% of portfolio
0.04%
Previous 0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 25, 2023

SELL
$39.56 - $47.22 $3,481 - $4,155
-88 Reduced 1.63%
5,311 $235,000
Q3 2022

Oct 11, 2022

BUY
$36.71 - $109.66 $198,197 - $592,054
5,399 New
5,399 $209,000
Q2 2022

Jul 13, 2022

SELL
$35.24 - $47.1 $187,159 - $250,148
-5,311 Closed
0 $0
Q1 2022

Apr 14, 2022

BUY
$40.9 - $45.1 $4,499 - $4,961
110 Added 2.11%
5,311 $235,000
Q1 2021

Apr 22, 2021

BUY
$35.27 - $39.67 $183,439 - $206,323
5,201 New
5,201 $201,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Boenning & Scattergood, Inc. Portfolio

Follow Boenning & Scattergood, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boenning & Scattergood, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Boenning & Scattergood, Inc. with notifications on news.